Vascular Dementia Global Market Report 2025

Description

Vascular dementia is a form of cognitive decline caused by reduced blood flow to the brain, often resulting from strokes or other vascular issues. This condition leads to memory loss and impaired thinking. Treatment for vascular dementia primarily focuses on managing underlying vascular conditions, such as controlling high blood pressure, diabetes, and cholesterol, along with promoting a healthy lifestyle to enhance brain health and slow the disease's progression.

Key products in the treatment of vascular dementia include monoclonal antibodies, small molecules, and peptides. Monoclonal antibodies are designed to target specific proteins or molecules related to the disease. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and are intended for use in hospitals, clinics, rehabilitation centers, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The vascular dementia market research report is one of a series of new reports from The Business Research Company that provides vascular dementia market statistics, including vascular dementia industry global market size, regional shares, competitors with a vascular dementia market share, detailed vascular dementia market segments, market trends and opportunities, and any further data you may need to thrive in the vascular dementia industry. This vascular dementia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular dementia market size has grown rapidly in recent years. It will grow from $2.92 billion in 2024 to $3.27 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing healthcare expenditure, rise in the number of patients diagnosed with vascular dementia, rise in healthcare professionals, growth in public health initiatives, and rise in the prevalence of diabetes.

The vascular dementia market size is expected to see rapid growth in the next few years. It will grow to $5.07 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing awareness of vascular dementia, rising healthcare investments, growing aging population, rising prevalence of cardiovascular diseases, and rising prevalence of high blood pressure. Major trends in the forecast period include technological advancements, personalized care plans, telemedicine, gene therapy, and artificial intelligence.

The forecast of 11.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of neuroprotective drugs and cerebral blood flow monitors sourced from France and Sweden, thereby slowing early intervention and elevating neurology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the vascular dementia market. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. Factors such as unhealthy lifestyles, poor dietary habits, physical inactivity, heightened stress levels, aging populations, and an increase in risk factors such as obesity, diabetes, and hypertension are contributing to the rise in cardiovascular diseases. These conditions increase the risk of vascular dementia by disrupting blood flow to the brain, which can lead to cognitive decline and brain cell damage due to insufficient oxygen and nutrients. For example, according to the British Heart Foundation in September 2024, approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with around 4 million men and 3.6 million women living with these conditions. These diseases are responsible for 27% of all deaths in the UK, totaling over 170,000 deaths annually, or about 480 deaths per day. As a result, the increasing prevalence of cardiovascular diseases is driving the growth of the vascular dementia market.

Companies in the vascular dementia market are focusing on developing new therapies, such as multimodal therapies, to maintain their competitive edge. Multimodal therapies combine various treatment approaches, including medications, physical therapy, and psychological interventions, to provide comprehensive treatment. For example, in January 2023, Moleac, a biopharmaceutical company based in Singapore, launched CognivAiD, an evidence-based treatment specifically designed for vascular dementia (VaD), a condition with few therapeutic options. This product combines active extracts from ginkgo, ginseng, and saffron, which have been shown to slow cognitive decline in VaD patients. The multimodal action of CognivAiD addresses key mechanisms of vascular dementia, such as vascular protection, vasoregulation, and neuroinflammation. Supported by extensive clinical trials and a strong safety profile, CognivAiD offers a promising new treatment for individuals with VaD.

In November 2023, Merck, a US-based pharmaceutical company, acquired Caraway Therapeutics, Inc. for an undisclosed amount. This acquisition is intended to accelerate the development of small-molecule therapeutics targeting neurodegenerative diseases, including Parkinson's disease and dementia. Caraway Therapeutics Inc. is a biopharmaceutical company based in the US, specializing in drug discovery and development for dementia.

Major players in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam's Group of Hospitals, Alpha Cognition Inc., and Citi Health.

North America was the largest region in the vascular dementia market in 2024. The regions covered in vascular dementia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vascular dementia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular dementia market consists of revenues earned by entities providing services such as diagnosis, treatment, care management, and support for individuals. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular dementia market includes sales of assistive devices, cognitive enhancers, and diagnostic tools. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including healthcare providers, wholesalers, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Dementia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular dementia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular dementia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular dementia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Monoclonal Antibodies; Small Molecules; Peptides
2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
3) By End User: Hospitals And Clinics; Rehabilitation Centers; Specialty Clinics
Subsegments:
1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies; Anti-Tau Monoclonal Antibodies
2) By Small Molecules: Cholinesterase Inhibitors; Glutamate Modulators; Anti-Inflammatory Small Molecules
3) By Peptides: Amyloid-Beta Targeted Peptides; Neuroprotective Peptides; Tau-Targeting Peptides
Companies Mentioned: Intermountain Healthcare Inc.; CSPC Ouyi Pharmaceutical Co. Ltd.; Duke Health; Massachusetts General Hospital; Emory Healthcare Inc.; Apollo Hospitals Enterprise Limited; Amedisys Inc.; Northwestern Memorial HealthCare; IBS Hospitals Pvt. Ltd.; Resverlogix Corp.; ProNeurogen Inc.; Cyclerion Therapeutics Inc.; Aribio Inc.; Pinteon Therapeutics Inc.; Dementech Neurosciences Ltd.; Moleac Pte. Ltd.; Isaac Health Inc.; Cadabam's Group of Hospitals; Alpha Cognition Inc.; Citi Health
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33928u

1. Executive Summary

2. Vascular Dementia Market Characteristics

3. Vascular Dementia Market Trends And Strategies

4. Vascular Dementia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Vascular Dementia Growth Analysis And Strategic Analysis Framework

5.1. Global Vascular Dementia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vascular Dementia Market Growth Rate Analysis
5.4. Global Vascular Dementia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vascular Dementia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vascular Dementia Total Addressable Market (TAM)

6. Vascular Dementia Market Segmentation

6.1. Global Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Small Molecules
Peptides
6.2. Global Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.3. Global Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Rehabilitation Centres
Speciality Clinics
6.4. Global Vascular Dementia Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Amyloid Monoclonal Antibodies
Anti-Tau Monoclonal Antibodies
6.5. Global Vascular Dementia Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cholinesterase Inhibitors
Glutamate Modulators
Anti-Inflammatory Small Molecules
6.6. Global Vascular Dementia Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amyloid-Beta Targeted Peptides
Neuroprotective Peptides
Tau-Targeting Peptides

7. Vascular Dementia Market Regional And Country Analysis

7.1. Global Vascular Dementia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vascular Dementia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Dementia Market

8.1. Asia-Pacific Vascular Dementia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Dementia Market

9.1. China Vascular Dementia Market Overview
9.2. China Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Dementia Market

10.1. India Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Dementia Market

11.1. Japan Vascular Dementia Market Overview
11.2. Japan Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Dementia Market

12.1. Australia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Dementia Market

13.1. Indonesia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Dementia Market

14.1. South Korea Vascular Dementia Market Overview
14.2. South Korea Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Dementia Market

15.1. Western Europe Vascular Dementia Market Overview
15.2. Western Europe Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Dementia Market

16.1. UK Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Dementia Market

17.1. Germany Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Dementia Market

18.1. France Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Dementia Market

19.1. Italy Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Dementia Market

20.1. Spain Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Dementia Market

21.1. Eastern Europe Vascular Dementia Market Overview
21.2. Eastern Europe Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Dementia Market

22.1. Russia Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Dementia Market

23.1. North America Vascular Dementia Market Overview
23.2. North America Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Dementia Market

24.1. USA Vascular Dementia Market Overview
24.2. USA Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Dementia Market

25.1. Canada Vascular Dementia Market Overview
25.2. Canada Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Dementia Market

26.1. South America Vascular Dementia Market Overview
26.2. South America Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Dementia Market

27.1. Brazil Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Dementia Market

28.1. Middle East Vascular Dementia Market Overview
28.2. Middle East Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Dementia Market

29.1. Africa Vascular Dementia Market Overview
29.2. Africa Vascular Dementia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vascular Dementia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vascular Dementia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Dementia Market Competitive Landscape And Company Profiles

30.1. Vascular Dementia Market Competitive Landscape
30.2. Vascular Dementia Market Company Profiles
- 30.2.1. Intermountain Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. CSPC Ouyi Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Duke Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Massachusetts General Hospital Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Emory Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Dementia Market Other Major And Innovative Companies

31.1. Apollo Hospitals Enterprise Limited
31.2. Amedisys Inc.
31.3. Northwestern Memorial HealthCare
31.4. IBS Hospitals Pvt. Ltd.
31.5. Resverlogix Corp.
31.6. ProNeurogen Inc.
31.7. Cyclerion Therapeutics Inc.
31.8. Aribio Inc.
31.9. Pinteon Therapeutics Inc.
31.10. Dementech Neurosciences Ltd.
31.11. Moleac Pte. Ltd.
31.12. Isaac Health Inc.
31.13. Cadabam's Group of Hospitals
31.14. Alpha Cognition Inc.
31.15. Citi Health

32. Global Vascular Dementia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Dementia Market

34. Recent Developments In The Vascular Dementia Market

35. Vascular Dementia Market High Potential Countries, Segments and Strategies

35.1 Vascular Dementia Market In 2029 - Countries Offering Most New Opportunities
35.2 Vascular Dementia Market In 2029 - Segments Offering Most New Opportunities
35.3 Vascular Dementia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer